Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Travaglino

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Haematology|December 18, 2007
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromesErica Travaglino, Chiara Benatti, Luca Malcovati, et al.
Blood|October 31, 2002
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemiaMario Cazzola, Rosangela Invernizzi, Gaetano Bergamaschi, et al.
Leukemia & Lymphoma|November 30, 2016
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implicationsRosangela Invernizzi, Erica Travaglino, Matteo Giovanni Della Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromesMatteo Giovanni Della Porta, Luca Malcovati, Emanuela Boveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision makingLuca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto, et al.
Haematologica|December 8, 2010
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeMatteo G Della Porta, Luca Malcovati, Corinna Strupp, et al.
Haematologica|June 11, 2011
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Luca Malcovati, Matteo G Della Porta, Corinna Strupp, et al.
Ejhaem|December 18, 2024
Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman diseaseMarco Lucioni, Gaia Morello, Caterina Cristinelli, et al.
Blood|March 10, 2005
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromesRamin Tehranchi, Rosangela Invernizzi, Alf Grandien, et al.
British Journal of Haematology|April 12, 2013
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitorsRosangela Invernizzi, Erica Travaglino, Matteo G Della Porta, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Haematology|December 18, 2007
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromesErica Travaglino, Chiara Benatti, Luca Malcovati, et al.
Blood|October 31, 2002
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemiaMario Cazzola, Rosangela Invernizzi, Gaetano Bergamaschi, et al.
Leukemia & Lymphoma|November 30, 2016
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implicationsRosangela Invernizzi, Erica Travaglino, Matteo Giovanni Della Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromesMatteo Giovanni Della Porta, Luca Malcovati, Emanuela Boveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision makingLuca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto, et al.
Haematologica|December 8, 2010
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeMatteo G Della Porta, Luca Malcovati, Corinna Strupp, et al.
Haematologica|June 11, 2011
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Luca Malcovati, Matteo G Della Porta, Corinna Strupp, et al.
Ejhaem|December 18, 2024
Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman diseaseMarco Lucioni, Gaia Morello, Caterina Cristinelli, et al.
Blood|March 10, 2005
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromesRamin Tehranchi, Rosangela Invernizzi, Alf Grandien, et al.
British Journal of Haematology|April 12, 2013
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitorsRosangela Invernizzi, Erica Travaglino, Matteo G Della Porta, et al.
Pageof 5